Andrew Cooper
Stock Analyst at Raymond James
(0.51)
# 4,070
Out of 4,463 analysts
202
Total ratings
39.9%
Success rate
-3.3%
Average return
Main Sectors:
Stocks Rated by Andrew Cooper
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ITGR Integer Holdings | Reiterated: Buy | $95 → $101 | $94.57 | +6.80% | 6 | Feb 23, 2026 | |
| GH Guardant Health | Reiterated: Buy | $61 → $129 | $170.77 | -24.46% | 11 | Feb 23, 2026 | |
| MYGN Myriad Genetics | Maintained: Buy | $8 | $6.00 | +33.33% | 9 | Jan 13, 2026 | |
| AZTA Azenta | Reiterated: Buy | $35 → $45 | $26.19 | +71.82% | 4 | Nov 25, 2025 | |
| AVTR Avantor | Downgraded: Hold | n/a | $10.01 | - | 15 | Nov 4, 2025 | |
| RVTY Revvity | Reiterated: Buy | $115 | $112.84 | +1.91% | 8 | Oct 28, 2025 | |
| HAE Haemonetics | Downgraded: Buy | $105 → $78 | $74.85 | +4.21% | 12 | Aug 11, 2025 | |
| QDEL QuidelOrtho | Maintained: Buy | $60 → $55 | $18.18 | +202.53% | 28 | Aug 6, 2025 | |
| FLGT Fulgent Genetics | Reiterated: Buy | $25 | $20.82 | +20.08% | 4 | Aug 4, 2025 | |
| TMO Thermo Fisher Scientific | Maintained: Buy | $525 → $535 | $513.33 | +4.22% | 7 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $193.72 | - | 7 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $269.38 | n/a | 1 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $14.97 | n/a | 16 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $85 → $175 | $276.27 | n/a | 9 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $29.25 | n/a | 25 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $4.58 | n/a | 1 | Jul 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $59.85 | n/a | 9 | Feb 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $4.32 | n/a | 14 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1,050 | $0.0001 | n/a | 11 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $26.15 | n/a | 2 | Feb 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $537.58 | n/a | 3 | Feb 2, 2021 |
Integer Holdings
Feb 23, 2026
Reiterated: Buy
Price Target: $95 → $101
Current: $94.57
Upside: +6.80%
Guardant Health
Feb 23, 2026
Reiterated: Buy
Price Target: $61 → $129
Current: $170.77
Upside: -24.46%
Myriad Genetics
Jan 13, 2026
Maintained: Buy
Price Target: $8
Current: $6.00
Upside: +33.33%
Azenta
Nov 25, 2025
Reiterated: Buy
Price Target: $35 → $45
Current: $26.19
Upside: +71.82%
Avantor
Nov 4, 2025
Downgraded: Hold
Price Target: n/a
Current: $10.01
Upside: -
Revvity
Oct 28, 2025
Reiterated: Buy
Price Target: $115
Current: $112.84
Upside: +1.91%
Haemonetics
Aug 11, 2025
Downgraded: Buy
Price Target: $105 → $78
Current: $74.85
Upside: +4.21%
QuidelOrtho
Aug 6, 2025
Maintained: Buy
Price Target: $60 → $55
Current: $18.18
Upside: +202.53%
Fulgent Genetics
Aug 4, 2025
Reiterated: Buy
Price Target: $25
Current: $20.82
Upside: +20.08%
Thermo Fisher Scientific
Jul 24, 2025
Maintained: Buy
Price Target: $525 → $535
Current: $513.33
Upside: +4.22%
Jul 23, 2025
Reiterated: Hold
Price Target: n/a
Current: $193.72
Upside: -
Mar 28, 2025
Initiated Coverage: Hold
Price Target: n/a
Current: $269.38
Upside: n/a
Feb 18, 2025
Reiterated: Hold
Price Target: n/a
Current: $14.97
Upside: n/a
Feb 10, 2025
Reiterated: Buy
Price Target: $85 → $175
Current: $276.27
Upside: n/a
May 13, 2024
Downgraded: Hold
Price Target: n/a
Current: $29.25
Upside: n/a
Jul 18, 2023
Initiated Coverage: Hold
Price Target: n/a
Current: $4.58
Upside: n/a
Feb 22, 2023
Reiterated: Hold
Price Target: n/a
Current: $59.85
Upside: n/a
Feb 15, 2023
Maintained: Hold
Price Target: n/a
Current: $4.32
Upside: n/a
Feb 24, 2022
Maintained: Buy
Price Target: $1,050
Current: $0.0001
Upside: n/a
Feb 11, 2021
Reiterated: Hold
Price Target: n/a
Current: $26.15
Upside: n/a
Feb 2, 2021
Reiterated: Hold
Price Target: n/a
Current: $537.58
Upside: n/a